We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Brain Imaging Studies Reveal Neurobiology of Eating Disorders

By LabMedica International staff writers
Posted on 30 Apr 2013
Current treatments for bulimia nervosa and anorexia are frequently inadequate and ineffective. More...
Patients have a tendency to relapse, become chronically ill, and have a higher risk of dying.

“A major reason contributing to the difficulty in developing new treatments for these disorders is our limited understanding of how brain function may contribute to eating disorder symptoms,” said Walter H. Kaye, MD, professor of psychiatry and director of the Eating Disorder Treatment and Research Program at the University of California (UC), San Diego School of Medicine (USA).

Recently, Dr. Kaye and colleagues reported the situation is changing. Cutting-edge brain imaging technologies, specifically functional magnetic resonance imaging (fMRI), supported by grants from the National Institute of Mental Health (Bethesda, MD, USA), are beginning to be used to study and improve eating disorder treatments. With funding from the Global Foundation for Eating Disorders (GFED; New York, NY, USA), a group that promotes eating disorder (ED) research and improved treatments, the UC San Diego Eating Disorders Center for Treatment and Research has launched a new initiative to create more effective ED therapies based upon brain imaging studies.

“Brain imaging research has allowed for a shift from simply describing a symptom to understanding the cause of a symptom,” said Dr. Kaye. “In the case of anorexia nervosa, imaging studies have helped us understand why people avoid eating and food and develop treatments that address the cause of the problem rather than secondary behaviors or symptoms. This is an important shift in the world of psychiatry similar to what revolutionized medical care decades ago. Today, if you show up at the doctor’s office with a bad cough, he or she might run diagnostics to determine whether the cough was bacterial or viral in order to administer the appropriate treatment. Similarly, the more we understand the specific causes of eating disorders, the more effective, and targeted our treatments can become.”

The UC San Diego program, under the directorship of Dr. Kaye, Kerri Boutelle, PhD, associate professor of pediatrics and psychiatry, Leslie Karwoski Anderson, PhD, clinical assistant professor of psychiatry and GFED scholars Stephanie Knatz and June Liang, is developing an imaging-based treatment strategy exclusively to handle the neurobiology of anorexia nervosa, in which patients obsess about being or becoming overweight. To prevent weight gain or lose weight, people with anorexia nervosa typical may starve themselves or exercise excessively.

Dr. Kaye reported that one neurobiologic target of anorexia and other eating disorders is anxiety. Most people get short-tempered when they do not eat and experience eating as both a reward and pleasant experience. Contrarily, anorexic individuals frequently feel severe anxiety when eating food, or even just anticipating eating, which results in severely reducing their food intake as a means of reducing their feelings of anxiety. “Recent imaging research has uncovered specific alterations in the brain associated with this link between food and anxiety in anorexic individuals,” said Dr. Kaye. “This finding is important because it helps explain the of cause food restriction, the most critical and dangerous behavior in anorexia.”

The UC San Diego researchers have used the new data to create new treatment strategies, including psychoeducation, i.e., teaching patients why symptoms occur and how to more effectively cope. “Many patients have described finally feeling a wave of relief after learning that the anxiety they experience is not their fault, but partly due to how their brain is responding to food,” stated Dr. Kaye. “Understanding why their eating disorder is driving them to restrict allows them to better target their anxiety around meals. Strategies such as developing routines before meals have shown promise in reducing the anticipatory anxiety leading up to meals and food restriction.”

Dr. Kaye noted that the brain-based therapy also benefits families of patients with eating disorders. “Through a better understanding of their family member’s eating disorder and its causes, family members have found comfort and hope with a ‘road map’ guiding them through the recovery.”

Related Links:
University of California, San Diego School of Medicine


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.